微小残留病
医学
淋巴细胞白血病
疾病
重症监护医学
急性白血病
白血病
家庭医学
免疫学
内科学
作者
Nicola Gökbuget,Nicolas Boissel,Sabina Chiaretti,Hervé Dombret,Michael Doubek,Adele K. Fielding,Robin Foà,Sebastian Giebel,Dieter Hoelzer,Mathilde Hunault,David I. Marks,Giovanni Martinelli,Oliver G. Ottmann,Anita W. Rijneveld,Philippe Rousselot,Josep‐María Ribera,Renato Bassan
出处
期刊:Blood
[Elsevier BV]
日期:2024-02-02
卷期号:143 (19): 1903-1930
被引量:19
标识
DOI:10.1182/blood.2023023568
摘要
Abstract Experts from the European Leukemia Net (ELN) working group for adult acute lymphoblastic leukemia have identified an unmet need for guidance regarding management of adult acute lymphoblastic leukemia (ALL) from diagnosis to aftercare. The group has previously summarized their recommendations regarding diagnostic approaches, prognostic factors, and assessment of ALL. The current recommendation summarizes clinical management. It covers treatment approaches, including the use of new immunotherapies, application of minimal residual disease for treatment decisions, management of specific subgroups, and challenging treatment situations as well as late effects and supportive care. The recommendation provides guidance for physicians caring for adult patients with ALL which has to be complemented by regional expertise preferably provided by national academic study groups.
科研通智能强力驱动
Strongly Powered by AbleSci AI